
|Slideshows|February 2, 2017
Neuro News Roundup: MS Biomarker & Second Stroke
Author(s)Mark L. Fuerst
Three new studies explore preventing secondary stroke, a potential biomarker for MS prediction, and a link between vitamin D and headache.
Advertisement
Three new studies in neurology -- one in stroke, one in headache, and one in multiple sclerosis (MS) -- include: the diabetes drug pioglitazone can help prevent secondary stroke in those with abnormal glucose metabolism; men with low blood levels of vitamin D have a higher risk of frequent headaches; and a biomarker may predict which patients with clinically isolated syndrome (CIS) may develop MS.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Remyelinating Agent PIPE-307 Falls Short in Phase 2 Trial of Relapsing Multiple Sclerosis
2
Brain-Penetrant Molecule GT-02287 Demonstrates Reversal of Glucosylsphinogosine in Parkinson Disease
3
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
4
Understanding Multiple Sclerosis (MS) Progression: Beyond Traditional Phenotypes
5






















